Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old ; volume:13 ; number:1 ; day:29 ; month:3 ; year:2023 ; pages:1-9 ; date:12.2023
Scientific reports ; 13, Heft 1 (29.3.2023), 1-9, 12.2023
- Urheber
-
John, Steven A.
Zapata, Juan P.
Dang, Madeline
Pleuhs, Benedikt
O’Neil, Andrew
Hirshfield, Sabina
Walsh, Jennifer L.
Petroll, Andrew E.
Quinn, Katherine G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-32014-8
- URN
-
urn:nbn:de:101:1-2023081421161786901866
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- John, Steven A.
- Zapata, Juan P.
- Dang, Madeline
- Pleuhs, Benedikt
- O’Neil, Andrew
- Hirshfield, Sabina
- Walsh, Jennifer L.
- Petroll, Andrew E.
- Quinn, Katherine G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pre-Exposure Prophylaxis (PrEP)
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis
Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Pre-Exposure Prophylaxis (PrEP)
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis
Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Pre-Exposure Prophylaxis (PrEP)
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis
Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil